We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
+6.58%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.55B
AUM Growth
+$102M
(+7%)
Cap. Flow
+$46.8M
Cap. Flow
% of AUM
3.03%
Top 10 Holdings %
Top 10 Hldgs %
47.84%
Holding
47
New
7
Increased
10
Reduced
12
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$72.5M |
| 2 |
Biogen
BIIB
|
+$58.1M |
| 3 |
HCA Healthcare
HCA
|
+$25.7M |
| 4 |
CF Industries
CF
|
+$16.6M |
| 5 |
TG Therapeutics
TGTX
|
+$15.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$50.3M |
| 2 |
STJ
St Jude Medical
STJ
|
+$50.1M |
| 3 |
MDCO
Medicines Co
MDCO
|
+$24.3M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$19.3M |
| 5 |
Televisa
TV
|
+$17.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.42% |
| 2 | Consumer Discretionary | 8.4% |
| 3 | Communication Services | 8.17% |
| 4 | Consumer Staples | 5.94% |
| 5 | Industrials | 5.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Post Holdings
POST
$4.15B
| $92M | 5.94% |
1,700,036
| – | – |
|
2
MGM Resorts International
MGM
$11.4B
| $89.6M | 5.79% |
3,958,970
| – | – |
|
|
MDCO
3
DELISTED
Medicines Co
MDCO
| $81.1M | 5.24% |
2,412,501
-688,797
| -22% | -$24.3M |
|
4
Labcorp
LH
$25.5B
| $80M | 5.16% |
714,561
-57,176
| -7% | -$6.15M |
|
5
Ironwood Pharmaceuticals
IRWD
$688M
| $77.4M | 5% |
7,065,690
+882,408
| +14% | +$8.62M |
|
|
MNK
6
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $72.1M | 4.66% |
+1,186,046
| New | +$72.5M |
|
|
WMGI
7
DELISTED
Wright Medical Group Inc
WMGI
| $69.1M | 4.46% |
3,979,841
+403,192
| +11% | +$7.4M |
|
8
Teva Pharmaceuticals
TEVA
$40.9B
| $65.5M | 4.23% |
1,304,572
+195,998
| +18% | +$10.4M |
|
|
AET
9
DELISTED
Aetna Inc
AET
| $57.8M | 3.73% |
473,099
-86,988
| -16% | -$9.99M |
|
10
DexCom
DXCM
$32.1B
| $56.2M | 3.63% |
2,833,580
-503,232
| -15% | -$8.57M |
|
11
Centene
CNC
$30.7B
| $54.3M | 3.5% |
1,520,390
+299,258
| +25% | +$9.4M |
|
|
12
Biogen
BIIB
$30.4B
| $53.3M | 3.44% |
+220,499
| New | +$58.1M |
|
13
Charter Communications
CHTR
$17.4B
| $52.5M | 3.39% |
229,504
-24,318
| -10% | -$5.23M |
|
14
Nektar Therapeutics
NKTR
$2.38B
| $51.2M | 3.31% |
239,904
+5,437
| +2% | +$1.22M |
|
15
Meta Platforms (Facebook)
META
$1.4T
| $48.1M | 3.1% |
420,598
| – | – |
|
|
GRUB
16
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $46.8M | 3.02% |
753,600
-74,134
| -9% | -$3.9M |
|
|
KSU
17
DELISTED
Kansas City Southern
KSU
| $40.5M | 2.62% |
449,703
-212,504
| -32% | -$19.3M |
|
|
WCG
18
DELISTED
Wellcare Health Plans, Inc.
WCG
| $40.1M | 2.59% |
374,143
+45,640
| +14% | +$4.46M |
|
19
Alnylam Pharmaceuticals
ALNY
$27.1B
| $38.1M | 2.46% |
687,009
-110,203
| -14% | -$6.94M |
|
20
Pacific Biosciences
PACB
$444M
| $36.5M | 2.35% |
5,182,239
+1,085,362
| +26% | +$9.91M |
|
21
VeriSign
VRSN
$26.2B
| $35.6M | 2.3% |
411,637
| – | – |
|
|
22
TG Therapeutics
TGTX
$8.01B
| $31.5M | 2.04% |
5,204,618
+1,859,149
| +56% | +$15.1M |
|
23
Liberty Broadband Class A
LBRDA
$4.9B
| $25.9M | 1.67% |
435,892
| – | – |
|
24
CALL
Ionis Pharmaceuticals
IONS
$8.55B
| $25.5M | 1.65% |
+1,095,000
| New | +$35.3M |
|
|
25
HCA Healthcare
HCA
$86.9B
| $25M | 1.62% |
+325,185
| New | +$25.7M |
|
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q2 2016 Portfolio in Review
As of Q2 2016, Bridger Management held 47 positions worth $1.55B, up 7% from $1.45B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Bridger Management deployed $46.8M of net new capital in Q2 2016, opening 7 new positions and adding to 10 existing holdings. Its largest new stake was MALLINCKRODT PUBLIC LIMITED COMPANY: 1,186,046 shares worth $72.1M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 51% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Medicines Co, an estimated $24.3M trimmed.
- Bridger Management's largest Q2 2016 buy was MALLINCKRODT PUBLIC LIMITED COMPANY: 1,186,046 shares worth $72.1M.
- Bridger Management added most to TG Therapeutics in Q2 2016, an estimated $15.1M increase.
- Bridger Management's biggest Q2 2016 reduction was Medicines Co, cutting an estimated $24.3M.
- Bridger Management fully exited UnitedHealth in Q2 2016, selling an estimated $50.3M.
- Bridger Management's ten largest holdings make up 48% of its $1.55B portfolio in Q2 2016.
- Bridger Management opened 7 new positions and closed 9 in Q2 2016.
- Bridger Management's portfolio value rose 7% quarter-over-quarter to $1.55B.
Based on Bridger Management's 13F filing for Q2 2016, filed 15 Aug 2016.